The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| 8EG | N/A | N/A | N/A | N/A |
| S&P | +13.95% | +78.35% | +12.25% | N/A |
euglena Co., Ltd. engages in the research, development, production and sale of microalgae products. It operates through the following segments: Healthcare; Bio Fuel, and Others. The Healthcare segment handles the planning and sale of in-house products, food products and cosmetics using algae. The Bio Fuel segment deals with funded research and technology development with a focus on microalgae. It also engages in the development of bio fuel production technology and investment in bio-tech related business. The Others segment covers agritech, bioinformatics, and social business. The company was founded by Mitsuru Izumo, Kengo Suzuki and Takuyuki Fukumoto on August 9, 2005 and is headquartered in Tokyo, Japan.
No news articles found for Euglena.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $72.74M | 2.6% |
| Gross Profit | $49.28M | -1.7% |
| Gross Margin | 67.75% | -3.0% |
| Market Cap | $355.10M | -6.3% |
| Market Cap / Employee | $395.88K | 0.0% |
| Employees | 897 | 0.0% |
| Net Income | $3.52M | 204.3% |
| EBITDA | $10.47M | 76.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $109.87M | -11.4% |
| Accounts Receivable | $24.80M | 5.2% |
| Inventory | 25 | -1.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $107.87M | -21.2% |
| Short Term Debt | $21.93M | -19.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 0.00% | 3.6% |
| Return On Invested Capital | -7.24% | 13.0% |
No data available for this period.
| Metric | Q3 2025 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 26335.52 | - | |||
| Price to Book | 1.77 | 2.17 | 1.74 | 1.97 | -5.68% |
| Price to Sales | 1.20 | 1.44 | 1.13 | 1.20 | -8.31% |
| Price to Tangible Book Value | -14.39 | -36.99 | -25.80 | -36.16 | -23.88% |
| Enterprise Value to EBITDA | 64.78 | 52.04 | 32.68 | 37.10 | -47.99% |
| Return on Equity | -2.4% | -4.3% | -3.2% | 0.0% | -100.02% |
| Total Debt | $159.25M | $157.09M | $133.62M | $129.80M | -20.92% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
